Novo Nordisk Repurchases DKK 10.56B of Shares Under Buyback Plan
Novo Nordisk said it bought back 37.85 million B shares for DKK 10.56B. Treasury stock now equals 1.2% of share capital.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
TradingView, citing a press release from Novo Nordisk A/S, reported an update on the company’s 12-month DKK 15 billion share-repurchase program, which began on 4 February 2026.
By 9 October 2026, Novo Nordisk had bought 37,849,179 B shares for a combined DKK 10.56 billion. The average purchase price was DKK 278.97 per share.
The company now holds 51,889,876 B shares in treasury, equivalent to 1.2% of its share capital. Total shares, including treasury stock, stand at 4.465 billion.
why it matters
The update confirms continued execution of a previously announced capital-return program. Buybacks reduce the free float and may affect earnings-per-share calculations; the market significance of the remaining program will depend on its pace. TradingView’s report is based on material distributed by GlobeNewswire, and the original source should be checked.
instruments
sources
- Novo Nordisk A/S (NOVO_B) Updates DKK 15B Buyback; 1.2% Treasury — TradingView, 12 October 2026 at 10:29 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗